Wilms Tumor

• 

  Subject Areas on Research

  • A new tumor marker for Wilm's tumor called hyaluronic acid-stimulating activity (HASA) 
  • Advances in the treatment of Wilms' tumor. Review of the experience at the Duke University Medical Center. 
  • An exploratory study of environmental and medical factors potentially related to childhood cancer. 
  • Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. 
  • B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. 
  • B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. 
  • BILATERAL DIFFUSE WILMS TUMOR: A CASE REPORT. 
  • Bilateral Wilms' tumor. Diagnosis and management. 
  • Bilateral diffuse Wilms tumor: a 5-year survival. 
  • Biomarkers for Wilms Tumor: A Systematic Review. 
  • Characterization of renal neoplasms with monoclonal antibodies to leukocyte differentiation antigens. 
  • Childhood cancer and occupational radiation exposure in parents. 
  • Comparing oncologic outcomes after minimally invasive and open surgery for pediatric neuroblastoma and Wilms tumor. 
  • Current concepts in the biology and management of Wilms tumor. 
  • Current concepts. Cancer in children. 
  • DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis. 
  • Decreased E-cadherin expression correlates with higher stage of Wilms' tumors. 
  • Developmental cystic renal neoplasms in children. Diagnostic imaging characteristics. 
  • Diagnosis and management of Wilms' tumor. 
  • Editorial comment. 
  • Editorial comment. 
  • Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases. 
  • High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor. 
  • Hyaluronic acid-stimulating activity in the pathophysiology of Wilms' tumors. 
  • Immunotherapeutic targeting of Wilms' tumor protein. 
  • Inflammatory pseudotumor of the liver masquerading as a metastasis in a child treated for nephroblastoma. 
  • Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program. 
  • Initial testing of cisplatin by the pediatric preclinical testing program. 
  • Intraoperative radiation therapy for Wilms' tumor in situ or ex vivo. 
  • Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. 
  • Management of solid tumors in children. 
  • Morphological survey of teleost organs important in carcinogenesis with attention to fixation. 
  • Multimodal therapy for stage IV adult Wilms tumor. 
  • Nephron-sparing approach to bilateral Wilms' tumor: in situ or ex vivo surgery and radiation therapy. 
  • Nephron-sparing surgery for Wilms tumor: A systematic review. 
  • Occurrence of Henoch-Schönlein purpura in a child with Wilms' tumor. 
  • Pediatric radiation oncology. 
  • Pleural malignant mesothelioma following Wilms' tumor. 
  • Preoperative angiographic embolization for large hemorrhagic Wilms' tumor. 
  • Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. 
  • Retroperitoneal lipoblastic tumors in children. 
  • Risk factors for Wilms tumor. Report from the National Wilms Tumor Study. 
  • Secretion of a large molecular-weight form of insulin-like growth factor by a primary renal tumor. 
  • Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors. 
  • Severe subcutaneous hemiatrophy following treatment of Wilms' tumor: CT demonstration. 
  • Significance of the "maturation" of metastases from Wilms' tumor after therapy. 
  • Synchronous occurrence of metastatic Wilms tumor and ganglioneuroma. 
  • The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus. 
  • The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells. 
  • Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. 
  • Urologic surgery. 
  • Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis. 
  • Vascular control for resection of suprahepatic intracaval Wilms' tumor: technical considerations. 
  • Wilms Tumor After Orthotopic Liver Transplant in a Patient With Alagille Syndrome. 
  • Wilms tumor imaging: patient costs and protocol compliance. 
  • Wilms tumor: a clinical pathological correlation. 
  • Wilms' tumor and paternal occupation. 
  • [Cystic nephroma]. 
• 

  Keywords of People

  • Hogan, Brigid L. M., George Barth Geller Distinguished Professor, Cell Biology
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics